Upgrades to Bayer Healthcare CT Contrast Injectors
Informational notice — track for solicitation
This opportunity is not yet open for proposals. Use this time to prepare — engaging early (capability statement, contacting the agency) can position you for the upcoming solicitation.
The Department of Health and Human Services is procuring three upgrades to existing Bayer Healthcare LLC CT contrast injectors for the National Institutes of Health Clinical Center's Radiology and Imaging Sciences Department. The upgrades are necessary to maintain compliance with FDA regulations and ensure the safety features and software integration of the injectors, which can only be performed by the original equipment manufacturer.
Want to track notices like this?
Get your fit score, win probability, and required capabilities.
Scope & Requirements
This acquisition involves upgrading CT contrast injectors to ensure compliance with regulatory standards and enhance operational safety and functionality.
Attachments
This listing does not include downloadable attachments. The solicitation details may be in the description below.
Verify on SAM.govContract Details
- Contract Typei
- FFP
- Estimated Value
- est. $15K – $45KSimilar contracts award $269 to $27K (median $6K, 44,054 awards)Above typical range
- Incumbent Contractor
- Bayer Healthcare LLC
- NAICS Codes
- Place of Performance
- Bethesda, MD, USA
Agency & Contact
Contracting Organization
- Agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Point of Contact
Key Dates
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Bayer Healthcare, LLC, located at 100 Bayer Blvd, Whippany, NJ 07981, on a firm fixed price sole source award basis to provide the required upgrades to the National Institutes of Health. CT contrast injectors require Original Equipment Manufacturer (OEM) upgrades to maintain compliance with FDA regulations, ensure calibration of life-critical pressure-limiting safety features, and guarantee seamless software integration with the CT imaging system. The existing Bayer contrast injectors use proprietary technology and can only be upgraded by the original equipment manufacturer (i.e., Bayer HealthCare). This upgrade is required to ensure the Radiology department continues to deliver high-quality, precise contrast-enhanced CT scans. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT),
contracting officers may solicit from one source if the
contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the
requirements of FAR Part 6-Competition
Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to [email protected] by July 24, 2026 at 5pm EST. Kristin Nagashima Contracting , SUITE 106 (No Street Address
2) BETHESDA, MD 20892 USA to this opportunity.
Get matched to contracts like this daily
Free AI-powered contract matching for your business.